Indo US Bio-Tech

{
  "main_header": {
    "sid": 1002989,
    "name": "Indo US Bio-Tech",
    "stock_name": "Indo US Bio-Tech",
    "full_name": "Indo US Bio-Tech Ltd",
    "name_url": "stocks-analysis/indo-us-bio-tech",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "77.61",
    "chg": -0.13,
    "chgp": "-0.17%",
    "dir": -1,
    "prev_price": "77.74",
    "mcapval": "159.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 541304,
    "symbol": "INDOUS",
    "ind_name": "Other Agricultural Products",
    "ind_code": 61,
    "sector_id": 53,
    "indexname": "India SENSEX",
    "isin": "INE250Z01010",
    "curr_date": "Sep 11, 03:30 PM",
    "curr_time": "00:51 AM",
    "last_traded_at": "Sep 11, 03:30 PM IST",
    "bse_nse_vol": "13.57 k",
    "exc_status": "Active",
    "traded_date": "Sep 11, 2026",
    "traded_date_str": "2026 09 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/indo-us-bio-tech-1002989-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Indo US Bio-Tech Ltd Falls to 52-Week Low of Rs 72.6 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indo-us-bio-tech-ltd-falls-to-52-week-low-of-rs726-amid-continued-underperformance-4182161",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/IndoUSBioTechLt_priceRelatedfactors_4182161.png",
        "date": "2026-09-04 09:54:33",
        "description": "After a three-day rally that lifted Indo US Bio-Tech Ltd by 5.54%, the stock slipped back to a fresh 52-week low of Rs 72.6 on 4 Sep 2026, extending its year-long decline to over 43%. This renewed weakness comes despite the broader market showing resilience, with the Sensex trading 0.68% higher on the day."
      },
      {
        "title": "Indo US Bio-Tech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indo-us-bio-tech-ltd-is-rated-sell-4177795",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/IndoUSBioTechLt_mojoScore_4177795.png",
        "date": "2026-09-01 10:10:26",
        "description": "Indo US Bio-Tech Ltd is rated Sell by MarketsMOJO. This rating was last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 01 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and overall outlook."
      },
      {
        "title": "Indo US Bio-Tech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indo-us-bio-tech-ltd-is-rated-sell-4159668",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/IndoUSBioTechLt_mojoScore_4159668.png",
        "date": "2026-08-18 10:10:22",
        "description": "Indo US Bio-Tech Ltd is rated Sell by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Indo US Bio-Tech Gains 0.69%: 3 Key Factors Driving the Week’s Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indo-us-bio-tech-gains-069-3-key-factors-driving-the-weeks-volatility-4155390",
        "imagepath": "",
        "date": "2026-08-15 12:03:17",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>10 Aug:</strong> Stock opened steady at Rs.81.00</p>\n                    <p><strong>12 Aug:</strong> Fell to 52-week low of Rs.79.97 amid underperformance</p>\n                    <p><strong>13 Aug:</strong> New 52-week low of Rs.75.7 amid continued downtrend</p>\n                    <p><strong>14 Aug:</strong> Downgraded to average quality; closed at Rs.81.56 (+4.55%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.81.00</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.81.56</div><di..."
      },
      {
        "title": "Indo US Bio-Tech Ltd Downgraded to Average Quality Amid Deteriorating Fundamentals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indo-us-bio-tech-ltd-downgraded-to-average-quality-amid-deteriorating-fundamentals-4152536",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/IndoUSBioTechLt_qualitydot_4152536.png",
        "date": "2026-08-14 08:00:22",
        "description": "Indo US Bio-Tech Ltd, a micro-cap player in the Other Agricultural Products sector, has seen its quality grade downgraded from good to average, prompting a shift in its Mojo Grade from Hold to Sell as of 19 Jan 2026. This downgrade reflects a deterioration in key business fundamentals, including returns on equity and capital employed, as well as concerns over growth consistency and leverage metrics. The stock has underperformed the broader market significantly over recent periods, raising questions about its near-term prospects."
      },
      {
        "title": "Markets Rally, But Indo US Bio-Tech Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indo-us-bio-tech-ltd-falls-to-52-week-low-of-rs757-amid-continued-downtrend-4151994",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/IndoUSBioTechLt_priceRelatedfactors_4151994.png",
        "date": "2026-08-13 11:04:41",
        "description": "Despite a broadly positive market environment, Indo US Bio-Tech Ltd has plunged to a fresh 52-week low of Rs 75.7 on 13 Aug 2026, marking a steep decline of over 52% from its peak of Rs 176.1 within the past year."
      },
      {
        "title": "Are Indo US Bio-Tech Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-indo-us-bio-tech-ltd-latest-results-good-or-bad-4150598",
        "imagepath": "",
        "date": "2026-08-12 19:38:26",
        "description": "Indo US Bio-Tech Ltd's latest financial results for Q4 FY26 reflect significant operational challenges. The company reported net sales of ₹26.02 crores, which represents a year-on-year decline of 22.05% from ₹33.38 crores in the same quarter last year. Although there was a sequential revenue improvement of 14.12% from ₹22.80 crores in Q3 FY26, this was insufficient to offset the year-on-year contraction, highlighting ongoing revenue volatility.\n\nThe net profit for the quarter stood at ₹1.97 crores, marking a substantial year-on-year decline of 46.47%. This decline in profitability was accompanied by a compression in profit after tax margins, which fell to 7.57% from 11.02% a year earlier. The operating margin also deteriorated significantly, reaching 12.38%, the lowest level in seven quarters, down from 23.51% in Q4 FY25. This indicates severe margin compression, raising concerns about the company's cost st..."
      },
      {
        "title": "Indo US Bio-Tech Ltd Falls to 52-Week Low of Rs 79.97 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indo-us-bio-tech-ltd-falls-to-52-week-low-of-rs7997-amid-continued-underperformance-4150451",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/IndoUSBioTechLt_priceRelatedfactors_4150451.png",
        "date": "2026-08-12 14:05:54",
        "description": "For the fifth consecutive session, Indo US Bio-Tech Ltd closed lower, slipping to a fresh 52-week low of Rs 79.97 on 12 Aug 2026. This decline comes amid a broader sector downturn and persistent underperformance relative to the benchmark indices."
      },
      {
        "title": "Indo US Bio-Tech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indo-us-bio-tech-ltd-is-rated-sell-4141574",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/IndoUSBioTechLt_mojoScore_4141574.png",
        "date": "2026-08-07 10:10:41",
        "description": "Indo US Bio-Tech Ltd is rated Sell by MarketsMOJO. This rating was last updated on 19 January 2026, reflecting a shift from the previous Hold status. However, the analysis and financial metrics discussed here represent the company’s current position as of 07 August 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and market performance."
      }
    ],
    "total": 259,
    "sid": "1002989",
    "stock_news_url": "https://www.marketsmojo.com/news/indo-us-bio-tech-1002989"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "06-Sep-2026",
      "details": "Notice of 22nd AGM of the company to be held 30th September 2026 through VC/OCAM published in Newspaper.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On Saturday 05Th September 2026.",
      "datetime": "05-Sep-2026",
      "details": "The Board met today discussed and resolved the agendas mentioned in attachment & attached Annexure A Book Closure Date (both days inclusive).",
      "source": "BSE"
    },
    {
      "caption": "Intimation Of Book Closure For The Purpose Of 22Nd AGM Pursuant To Regulation 42 Of SEBI (LODR)",
      "datetime": "05-Sep-2026",
      "details": "Book closure period from 23rd September 2026 to 30th September 2026 (Both inclusive days) for the purpose of 22nd AGM of the company to be held on 30th Sep 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Indo US Bio-Tech Ltd has declared <strong>2%</strong> dividend, ex-date: 03 Dec 24",
          "dt": "2024-12-03",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Indo US Bio-Tech Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 29 Aug 23",
          "dt": "2023-08-29",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Indo US Bio-Tech Ltd Falls to 52-Week Low of Rs 72.6 as Sell-Off Deepens

2026-09-04 09:54:33

After a three-day rally that lifted Indo US Bio-Tech Ltd by 5.54%, the stock slipped back to a fresh 52-week low of Rs 72.6 on 4 Sep 2026, extending its year-long decline to over 43%. This renewed weakness comes despite the broader market showing resilience, with the Sensex trading 0.68% higher on the day.

Read full news article

Indo US Bio-Tech Ltd is Rated Sell

2026-09-01 10:10:26

Indo US Bio-Tech Ltd is rated Sell by MarketsMOJO. This rating was last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 01 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and overall outlook.

Read full news article

Indo US Bio-Tech Ltd is Rated Sell

2026-08-18 10:10:22

Indo US Bio-Tech Ltd is rated Sell by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Indo US Bio-Tech Gains 0.69%: 3 Key Factors Driving the Week’s Volatility

2026-08-15 12:03:17

Key Events This Week

10 Aug: Stock opened steady at Rs.81.00

12 Aug: Fell to 52-week low of Rs.79.97 amid underperformance

13 Aug: New 52-week low of Rs.75.7 amid continued downtrend

14 Aug: Downgraded to average quality; closed at Rs.81.56 (+4.55%)

Week Open

Rs.81.00

Week Close

Rs.81.56

Read full news article

Indo US Bio-Tech Ltd Downgraded to Average Quality Amid Deteriorating Fundamentals

2026-08-14 08:00:22

Indo US Bio-Tech Ltd, a micro-cap player in the Other Agricultural Products sector, has seen its quality grade downgraded from good to average, prompting a shift in its Mojo Grade from Hold to Sell as of 19 Jan 2026. This downgrade reflects a deterioration in key business fundamentals, including returns on equity and capital employed, as well as concerns over growth consistency and leverage metrics. The stock has underperformed the broader market significantly over recent periods, raising questions about its near-term prospects.

Read full news article

Markets Rally, But Indo US Bio-Tech Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-08-13 11:04:41

Despite a broadly positive market environment, Indo US Bio-Tech Ltd has plunged to a fresh 52-week low of Rs 75.7 on 13 Aug 2026, marking a steep decline of over 52% from its peak of Rs 176.1 within the past year.

Read full news article

Are Indo US Bio-Tech Ltd latest results good or bad?

2026-08-12 19:38:26

Indo US Bio-Tech Ltd's latest financial results for Q4 FY26 reflect significant operational challenges. The company reported net sales of ₹26.02 crores, which represents a year-on-year decline of 22.05% from ₹33.38 crores in the same quarter last year. Although there was a sequential revenue improvement of 14.12% from ₹22.80 crores in Q3 FY26, this was insufficient to offset the year-on-year contraction, highlighting ongoing revenue volatility. The net profit for the quarter stood at ₹1.97 crores, marking a substantial year-on-year decline of 46.47%. This decline in profitability was accompanied by a compression in profit after tax margins, which fell to 7.57% from 11.02% a year earlier. The operating margin also deteriorated significantly, reaching 12.38%, the lowest level in seven quarters, down from 23.51% in Q4 FY25. This indicates severe margin compression, raising concerns about the company's cost st...

Read full news article

Indo US Bio-Tech Ltd Falls to 52-Week Low of Rs 79.97 as Sell-Off Deepens

2026-08-12 14:05:54

For the fifth consecutive session, Indo US Bio-Tech Ltd closed lower, slipping to a fresh 52-week low of Rs 79.97 on 12 Aug 2026. This decline comes amid a broader sector downturn and persistent underperformance relative to the benchmark indices.

Read full news article

Indo US Bio-Tech Ltd is Rated Sell

2026-08-07 10:10:41

Indo US Bio-Tech Ltd is rated Sell by MarketsMOJO. This rating was last updated on 19 January 2026, reflecting a shift from the previous Hold status. However, the analysis and financial metrics discussed here represent the company’s current position as of 07 August 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and market performance.

Read full news article

View All News